Breaking
Lilly adds to immune drug pipeline with $2.9B Merida buyout
Cornell University Scientists Achieve Breakthrough in Reversible Nonhormonal Male Contraception Through Targeted Meiosis Interruption
Personalized Vitamin D3 Treatment Halves Recurrence Risk of Heart Attacks in New Study
Immune System Recognition of Latent Toxoplasma gondii Cysts Challenges Longstanding Scientific Assumptions Regarding Brain Infections
Fear of breast cancer recurrence: Impact and coping with being in a dark place
New molecular map reveals how the flu virus hijacks human cells
Experimental Immunotherapy Targets Tumor-Protecting Cells to Overcome Metastatic Cancer Resistance
Millions may be getting the wrong cholesterol test
Children Exposed to Second-Hand Smoke at Home Exhibit Epigenetic Changes Linked to Future Disease Risk
The Bone Marrow Microenvironment Plays a Pivotal Role in the Early Development of Blood Cancers and Age-Related Diseases
1 Sep 2026, Tue

Billy Candra

You Missed

Biotech, Pharma & Cancer Drug Development

Lilly adds to immune drug pipeline with $2.9B Merida buyout

Genitourinary, Prostate & Kidney Cancer

Cornell University Scientists Achieve Breakthrough in Reversible Nonhormonal Male Contraception Through Targeted Meiosis Interruption

Hematology, Leukemia & Lymphoma

Personalized Vitamin D3 Treatment Halves Recurrence Risk of Heart Attacks in New Study

Gynecologic Oncology (Ovarian, Cervical)

Immune System Recognition of Latent Toxoplasma gondii Cysts Challenges Longstanding Scientific Assumptions Regarding Brain Infections